Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2020-10-27 Capital/Financing Update
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Appendix 3G 12 pages 256.8KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3G form submitted to the ASX (Australian Securities Exchange) regarding the notification of issue, conversion, or payment up of equity securities. It includes detailed information about the securities issued, the entity, and the purpose of the issue. This type of document is a regulatory announcement related to capital changes, specifically the issuance of new securities or options. It is not a full financial report, earnings release, or management discussion. It is a formal notification of a capital/financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication announcement, but a substantive filing about capital changes.
2020-10-27 English
Change of Director's Interest Notice - Alan Yamashita 2 pages 153.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of options held before and after the change, nature of the change, and dates. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3513 characters, which is consistent with a detailed notice rather than a brief announcement. There is no indication that this is an annual report, audit report, or any other type of filing. Therefore, the correct classification is Director's Dealing (DIRS).
2020-10-27 English
Change of Director's Interest Notice - Thian Chew 2 pages 153.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including the number of shares and options held before and after the change, nature of the interest, and dates. This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives. The document is not an announcement of a report, nor a full financial report, but a specific notice of director's share transactions.
2020-10-27 English
Director Appointment 2 pages 154.1KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 26 October 2020 regarding the appointment of Alistair Bennallack as a Non-Executive Director to the Board of Invion Limited. The content focuses exclusively on the change in the company's board composition, detailing the new director's background and qualifications. There is no financial data, no mention of a report or financial results, and the document is relatively short (3,495 characters). This fits the definition of a Board/Management Information filing, which covers announcements of changes in the company's board of directors or senior management.
2020-10-25 English
Activities Report and Appendix 4C 7 pages 320.4KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement titled 'Activity Report and Cash Flow Report for the Quarter Ended 30 September 2020'. It includes detailed quarterly cash flow statements (Appendix 4C) and commentary on the company's cash position, R&D activities, and management changes during the quarter. The presence of the Appendix 4C quarterly cash flow report, which is a regulatory requirement for ASX-listed entities, indicates this is a quarterly financial report. The document contains substantive financial data and analysis for a period shorter than a full fiscal year (the quarter ended 30 September 2020). It is not merely an announcement of a report or a certification letter. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2020
2020-10-25 English
AGM Presentation 13 pages 742.2KB
Regulatory Filings
2020-10-20 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.